Transurethral Fulguration Alleviates Pelvic Pain in Interstitial Cystitis
MONDAY, May 5, 2025 -- For patients with interstitial cystitis (IC), transurethral fulguration (TUF) is effective for alleviating pelvic pain, according to a study published online April 3 in Neurourology and Urodynamics.
Hyun Ju Jeong, from the Seoul National University College of Medicine in South Korea, and colleagues conducted a retrospective analysis of electronic medical records of patients with IC who visited outpatient clinics with pelvic pain. Cystoscopic surgery based on TUF for bladder ulcers was used to manage pain; intractable pelvic pain was treated with cystectomy.
Overall, 240 of 275 patients underwent initial cystoscopic surgery; the mean number of TUF procedures was 1.0 during a median follow-up of 21.0 months. The researchers found that 71 of the 240 patients (29.6 percent) did not require further surgical treatment, while 26.7 percent required a second TUF for recurrent pelvic pain, with a median recurrence interval of 12.0 months. Fifteen of the 64 patients who received a second TUF (23.4 percent) underwent a third TUF after a median of 12.0 months. Five of the 15 patients who received a third TUF underwent a fourth TUF due to pain recurrence. One patient received a seventh TUF. Pain control with TUF was achieved by 168 of the 240 patients (70.0 percent). Eighteen (7.5 percent) of the patients underwent cystectomy.
"Our study results showed that TUFâbased cystoscopic surgery is an effective basic treatment for pelvic pain management in patients with IC," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Read this next
Neonatal Male Circumcision Rates Reduced From 2012 to 2022
FRIDAY, Sept. 19, 2025 -- U.S. neonatal male circumcision (NMC) rates declined nearly 5 percent in the 10 years following the American Academy of Pediatrics statement supporting...
Surgical Volume Increases With Introduction of HoLEP
FRIDAY, Sept. 19, 2025 -- Introducing holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia increases surgical volume in urology practices, according...
Lung Cancer Screening Beneficial to Age 80 for Candidates Fit for Surgery
FRIDAY, Sept. 12, 2025 -- People aged 75 to 80 years at last screen who are diagnosed with screen-detected lung cancer (LC) have lower overall survival, but those undergoing...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.